Medicare Enrolled

Dr. Richard Carter, MD

Hematology & Oncology · Conyers, GA
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Low-engagement
1498 KLONDIKE RD SW, Conyers, GA 30094
7707617260
In practice since 2006 (20 years)
NPI: 1083660104 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Carter from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Carter? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Carter

Dr. Richard Carter is a hematology & oncology specialist in Conyers, GA, with 20 years of NPI registration. Based on federal Medicare data, Dr. Carter performed 666 Medicare services across 332 unique beneficiaries.

Between the years covered by Open Payments, Dr. Carter received a total of $7,331 from 61 pharmaceutical and/or device companies across 296 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hematology & oncology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Carter is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice ▲ 666 Medicare services $7,331 industry payments

Medicare Practice Summary

Medicare Utilization ↗
666
Medicare services
Bottom 48% in GA for hematology & oncology
332
Unique beneficiaries
$63
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~33 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
444 $70 $314
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
174 $45 $213
Hospital follow-up visit, low complexity
Follow-up hospital visit for an established patient with straightforward or low-level medical decision making. The visit requires at least 25 minutes of time spent on the day of service.
34 $37 $115
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
14 $98 $484
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$7,331
Total received (2018-2024)
Avg $1,047/year across 7 years
Top 38% in GA for hematology & oncology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
61
Companies
296
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$6,783 (92.5%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$548 (7.5%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$1,781
2023
$2,353
2022
$964
2021
$258
2020
$205
2019
$1,151
2018
$618

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
PFIZER INC.
$289
BeiGene USA, Inc.
$180
AstraZeneca Pharmaceuticals LP
$122
Janssen Biotech, Inc.
$115
Daiichi Sankyo Inc.
$112
ABBVIE INC.
$89
Alexion Pharmaceuticals, Inc.
$85
Merck Sharp & Dohme LLC
$63
Novartis Pharmaceuticals Corporation
$59
Celgene Corporation
$50
Stemline Therapeutics Inc.
$49
Takeda Pharmaceuticals U.S.A., Inc.
$46
Lilly USA, LLC
$44
ARRAY BIOPHARMA INC
$43
Eisai Inc.
$42
JAZZ PHARMACEUTICALS INC.
$39
PharmaEssentia USA Corporation
$37
Genentech USA, Inc.
$34
Ipsen Biopharmaceuticals, Inc
$33
Bayer Healthcare Pharmaceuticals Inc.
$30
Karyopharm Therapeutics Inc.
$30
Pharmacosmos Therapeutics Inc.
$27
Astellas Pharma US Inc
$26
GENZYME CORPORATION
$26
PUMA BIOTECHNOLOGY, INC.
$25
Sirtex Medical Inc
$24
GlaxoSmithKline, LLC.
$22
SOBI, INC
$19
Agios Pharmaceuticals, Inc.
$18
Top 3 companies account for 33.2% of 2024 payments
All-time payments by company (2018-2024) ›
AstraZeneca Pharmaceuticals LP
$609
Intuitive Surgical, Inc.
$524
PFIZER INC.
$354
Sirtex Medical Inc
$322
BeiGene USA, Inc.
$319
Janssen Biotech, Inc.
$306
Novartis Pharmaceuticals Corporation
$305
Genentech USA, Inc.
$292
Exelixis Inc.
$270
GENZYME CORPORATION
$244
E.R. Squibb & Sons, L.L.C.
$231
Seagen Inc.
$222
Astellas Pharma US Inc
$214
Takeda Pharmaceuticals U.S.A., Inc.
$166
Alexion Pharmaceuticals, Inc.
$154
SOBI, INC
$143
Lilly USA, LLC
$142
Ipsen Biopharmaceuticals, Inc
$141
Daiichi Sankyo Inc.
$138
GlaxoSmithKline, LLC.
$132
Eisai Inc.
$129
Stemline Therapeutics Inc.
$128
Celgene Corporation
$120
Pharmacosmos Therapeutics Inc.
$112
ABBVIE INC.
$112
Bayer Healthcare Pharmaceuticals Inc.
$110
Merck Sharp & Dohme LLC
$110
Merck Sharp & Dohme Corporation
$106
Medtronic USA, Inc.
$103
ARRAY BIOPHARMA INC
$88
Amgen Inc.
$82
Pharmacyclics LLC, An AbbVie Company
$75
Foundation Medicine, Inc.
$72
Rigel Pharmaceuticals, Inc.
$66
JAZZ PHARMACEUTICALS INC.
$62
Gilead Sciences, Inc.
$51
Dendreon Pharmaceuticals LLC
$44
Puma Biotechnology, Inc.
$39
PharmaEssentia USA Corporation
$37
Agios Pharmaceuticals, Inc.
$35
Karyopharm Therapeutics Inc.
$30
Taiho Oncology, Inc.
$30
PUMA BIOTECHNOLOGY, INC.
$25
Mirati Therapeutics, Inc.
$25
AVEO Pharmaceuticals, Inc.
$25
Pharmacyclics LLC, an AbbVie Company
$21
Coherus Biosciences Inc.
$20
Global Blood Therapeutics, Inc.
$20
Acrotech Biopharma LLC
$20
AbbVie Inc.
$20
Incyte Corporation
$19
G1 Therapeutics, Inc.
$19
CTI BioPharma Corp.
$19
Janssen Pharmaceuticals, Inc
$19
Mylan Institutional Inc.
$19
Bayer HealthCare Pharmaceuticals Inc.
$18
TESARO, Inc.
$17
Deciphera Pharmaceuticals Inc.
$16
Sobi, Inc
$16
Emmaus Medical, Inc.
$12
AbbVie, Inc.
$11
Top 3 companies account for 20.3% of all-time payments
Associated products mentioned in payments ›
ADAKVEO · ADCETRIS · ALUNBRIG · Alecensa · Avastin · BELEODAQ · BESREMI · BOSULIF · BRAFTOVI · BRUKINSA · CABOMETYX · CALQUENCE · COSELA · CYRAMZA · Cabometyx · Columvi · Creon · DARZALEX · DOPTELET · Da Vinci Surgical System · Doptelet · ELIQUIS · ELITEK · ELREXFIO · ELZONRIS · ERLEADA · Endari · Enhertu · Erleada · FASLODEX · FOTIVDA · FOUNDATIONONE · FRUZAQLA · Fulphila · GAZYVA · IBRANCE · ICLUSIG · IMBRUVICA · IMFINZI · INLYTA · Imbruvica · Itovebi · JEMPERLI · KEYTRUDA · KISQALI · KRAZATI · Kadcyla · Kyprolis · LIBTAYO · LONSURF · LORBRENA · LUMAKRAS · LUPRON DEPOT · LUTATHERA · LYNPARZA · Lenvima · Lunsumio · MEKINIST · MONJUVI · MONOFERRIC · MVASI · NINLARO · Nubeqa · OJJAARA · OPDUALAG · OSTEOCOOL RF ABLATION · OXBRYTA · Orserdu · PADCEV · PLUVICTO · PROVENGE · PYRUKYND · Padcev · Perjeta · Phesgo · QINLOCK · REBLOZYL · RETACRIT · RYBREVANT · Rezlidhia · SARCLISA · SCEMBLIX · SIR-Spheres Microspheres · SOMATULINE DEPOT · Stivarga · TAGRISSO · TECENTRIQ · TECVAYLI · TEVIMBRA · TUKYSA · Tavalisse · Tazverik · Trodelvy · ULTOMIRIS · Udenyca · VENCLEXTA · VERZENIO · VOTRIENT · Vonjo · XARELTO · XGEVA · XPOVIO · XTANDI · ZEJULA · ZEPZELCA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (92%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for a hematology & oncology specialist in Conyers?
Compare hematology & oncology specialists in the Conyers area by procedure volume, costs, and industry payment transparency.
Browse hematology & oncology specialists nearby

Geographic Context

Hematology & oncology specialists within 10 mi
115
Per 100K population
122.0
County median income
$72,349
Nearest hospital
PIEDMONT ROCKDALE HOSPITAL
7.8 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Carter is a clinical cardiology specialist, with moderate Medicare volume, with low-engagement industry engagement, with 20 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Carter experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Carter performed 444 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Carter receive payments from pharmaceutical companies?
Yes. Dr. Carter received a total of $7,331 from 61 companies across 296 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Carter's costs compare to other hematology & oncology specialists in Conyers?
Dr. Carter's average Medicare payment per service is $63. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Carter) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →